Table 8 Drug of choice for treatment of malaria and availability of acts in health facilities
Variables | Public N =36 N (%) | Private N =38 N (%) | Chi-square (p-value) |
|---|---|---|---|
Drugs used by respondents as first line in the treatment of malaria | Â | Â | Â |
Artemisinin-Based Combination Therapy | 32 (88.8) | 13 (34.2) | 23.19 (0.0001) |
Sulfadoxine-Pyrimethamine (SP) | 2 (5.6) | 12 (31.6) | 8.16 (0.004) |
Chloroquine | 2 (5.6) | 10 (26.3) | 5.86 (0.015) |
Artemisinin Monotherapy | 0 (0.00) | 3 (7.9) | 2.96 (0.085) |
ACTs available at the time of the survey | 32 (88.8) | 17 (44.7) | 21.29 (0.0001) |
Types of ACTs seen in the facility | Â | Â | Â |
Artemether-Lumefantrine (AL) | 30 (83.3) | 14 (36.8) | 16.58 (0.0001) |
Artesunate+Amodiaquine (AA) | 13 (36.1) | 5 (13.2) | 5.29 (0.021) |
Dihydroartemisinin-Piperaquine (DP) | 16 (44.4) | 8 (21.1) | 4.62 (0.032) |
Various sources of the ACTs in health facilities | Â | Â | Â |
Government | 35 (97.2) | 9 (23.7) | 41.47 (0.0001) |
NGO | 2 (5.6) | 0 (0.0) | 2.17 (0.233)F |
Purchase from the market | 0 (0.0) | 26 (68.4) | 37.97 (0.0001) |
Others | 1(2.7) | 1(2.6) | 0.00 (0.739)F |